Anti-inflammatory activity of the non-peptidyl low molecular weight radical scavenger IAC in carrageenan-induced oedema in rats

Journal of Pharmacy and Pharmacology

Volumn 63, Issue 3, 2011, Pages 417-422

  Corsi, Lorenzo ^a   Zavatti, Manuela ^a   Geminiani, Elisa ^a   Zanoli, Paola ^a   Baraldi, Mario ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Carrageenan; Cytokines; IAC; Inflammation; Interleukins

Indexed keywords

ANTIINFLAMMATORY AGENT; BIS(1 HYDROXY 2,2,6,6 TETRAMETHYL 4 PIPERIDINYL)DECANDIOATE; CARRAGEENAN; GLUTATHIONE; INDOMETACIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; SCAVENGER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GRANULOMA; INFLAMMATION; MALE; NONHUMAN; PAW EDEMA; PROTEIN BLOOD LEVEL; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CARRAGEENAN; DISEASE MODELS, ANIMAL; DOWN-REGULATION; EDEMA; FREE RADICAL SCAVENGERS; GLUTATHIONE; GRANULOMA, FOREIGN-BODY; INTERLEUKIN-1ALPHA; INTERLEUKIN-2; INTERLEUKIN-6; MALE; MOLECULAR WEIGHT; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79952226016     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2010.01233.x     Document Type: Article

References (34)

1. Valgimigl L et al. Measurement of oxidative stress by EPR radical-probe technique. Free Radic Biol Med 2001; 31: 708-716.
2. Novelli M et al. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a non-obese mouse diabetes model. Pancreas 2007; 35: 10-17.
3. Vasina V et al. Effects of the non-peptidyl low molecular weight radical scavenger IAC in DNBS-induced colitis in rats. Eur J Pharmacol 2009; 614: 137-145.
4. Vasina V et al. Non-peptidyl low molecular weight radical scavenger IAC attenuates DSS-induced colitis in rats. World J Gastroenterol 2010; 16: 3642-3650.
5. Mancarella R et al. Beneficial effect of the nonpeptidyl low molecular weight radical scavenger IAC on cultured human islet function. Cell Transplant 2008; 17: 1271-1276.
6. Fantone JC, Ward PA. Role of oxygen-derived free radicals and metabolites in leukocyte dependent inflammatory reactions. Am J Pathol 1982; 107: 395-418.
7. Moncada S, Higg EA. Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur J Clin Invest 1991; 21: 361-374.
8. Cuzzocrea S et al. The protective role of endogenous glutathione in carrageenan-induced pleurisy in the rat. Eur J Pharmacol 1999; 372: 187-197. (Pubitemid 29251291)
9. Gualillo O et al. Evaluated serum leptin concentrations induced by experimental acute inflammation. J Ethnopharmacol 2001; 75: 213-218.
10. Loram LC et al. Behavioural, histological and cytokine responses during hyperalgesia induced by carrageenan injection in the rat tail. Physiol Behav 2007; 92: 873-880. (Pubitemid 350110457)
11. Toriyabe M et al. Contribution of interaction between nitric oxide and cyclooxygenases to the production of prostaglandins in carrageenan-induced inflammation. Anesthesiology 2004; 101: 983-990. (Pubitemid 39288050)
12. Loram LC et al. The time course of inflammatory cytokine secretion in a rat model of postoperative pain does not coincide with the onset of mechanical hyperalgesia. Can J Physiol Pharmacol 2007; 85: 613-620. (Pubitemid 47518030)
13. Stassen M et al. Classical and alternative pathways of mast cell activation. Crit Rev Immunol 2002; 22: 115-140. (Pubitemid 35244754)
14. Oka Y et al. Interleukin-6 is a candidate molecule that transmits inflammatory information to the CNS. Neuroscience 2007; 145: 530-538. (Pubitemid 46341642)
15. Mika J et al. Interleukin-1 alpha has antiallodynic and antihyperalgesic activities in a rat neuropathic pain model. Pain 2008; 13: 587-597.
16. Feghali CA, Wright TM. Cytochines in acute and chronic inflammation. Front Biosci 1997; 2: 12-26.
17. Arai KI et al. Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem 1991; 59: 783-836.
18. Zeng H et al. Huang-Lian-Jie-Du-Tang exerts anti-inflammatory effects in rats through inhibition of nitric oxide production and eicosanoid biosynthesis via the lipoxygenase pathway. J Pharm Pharmacol 2009; 61: 1699-1707.
19. Ghosh S et al. Anti-inflammatory and anticancer compounds isolated from Ventilago madraspatana Gaertn., Rubia cordifolia Linn. and Lantana camara Linn. J Pharm Pharmacol 2010; 62: 1158-1166.
20. Barros TAD et al. Antinociceptive and anti-inflammatory properties of 7-hydroxycoumarin in experimental animal models: potential therapeutic for the control of inflammatory chronic pain. J Pharm Pharmacol 2010; 62: 205-213.
21. Jun HJ et al. Evaluation of anti-angiogenic, anti-inflammatory and antinociceptive activity of coenzyme Q(10) in experimental animals. J Pharm Pharmacol 2009; 61: 1391-1395.
22. Alves CF et al. Anti-inflammatory activity and possible mechanism of extract from Mikania laevigata in carrageenan-induced peritonitis. J Pharm Pharmacol 2009; 61: 1097-1104.
23. Dutra RC et al. Antiulcerogenic anti anti-inflammatory activities of the essential oil from Pterodon emarginatus seeds. J Pharm Pharmacol 2009; 61: 243-250.
24. Zavatti M et al. Anti-ulcer activity of IAC, a novel free-radical scavenger, in rats. J Pharm Pharmacol 2009; 61: 395-397.
25. Winter CA et al. Carrageenan-induced oedema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 1962; 111: 544-547.
26. Zanoli P et al. Influence of 2,4-tetra-O-methyl-furfurylidenesorbitol (MSF) on carrageenan-induced inflammation and antiinflammatory and toxic effects of indomethacin in rats. Agents Actions 1982; 12: 521-526. (Pubitemid 13218986)
27. Schiatti P et al. Highly selective anti-inflammatory and analgesic activity of 3-(1-methyl-ethyl)-2-(4-methoxyphenyl)-3Hnaphth(1,2-d)imidazole, a new non-acidic molecule. Arzneimittelforschung 1986; 36: 102-109. (Pubitemid 16184298)
28. D'Aleo V et al. The non-peptidyl low molecular weight radical scavenger IAC protects human pancreatic islets from lipotoxicity. Mol Cell Endocrinol 2009; 309: 63-66.
29. Portanova JP et al. Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J Exp Med 1996; 184: 883-891.
30. Ghosh AK et al. Cyclooxygenase-2-mediated angiogenesis in carrageenan-induced granulation tissue in rats. J Pharmacol Exp Ther 2000; 295: 802-809.
31. Feitoza CQ et al. Inhibition of COX 1 and 2 prior to renal ischemia/reperfusion injury decreases the development of fibrosis. Mol Med 2008; 14: 724-730.
32. Alebouyeh M et al. Increase in serum level of interleukin-1 alpha mediates morphine anti-inflammatory effect in carrageenan-induced paw oedema in mice. Cytokine 2002; 19: 102-105.
33. Choudhry MA et al. Prostaglandin E2 down-regulation of T cell IL-2 production is independent of IL-10 during gram-negative sepsis. Immunol Lett 1999; 67: 125-130. (Pubitemid 29191531)
34. El-Shitany NA et al. Thioctic acid protects against carrageenan-induced acute inflammation in rats by reduction in oxidative stress, downregulation of COX-2 mRNA and enhancement of IL-10 mRNA. Fundam Clin Pharmacol 2010; 24: 91-99.